EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health

Informazioni relative al progetto

EBRAINS 2.0

ID dell’accordo di sovvenzione: 101147319

DOI 10.3030/101147319

Data della firma CE 14 Dicembre 2023

Data di avvio 1 Gennaio 2024

Data di completamento 31 Dicembre 2026

Finanziato da

• Research infrastructures

Costo totale € 37 995 202,50

Contributo UE € 37 995 202,50

Coordinato da

EBRAINS
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (8)

D3.6 Co-design strategy for WP3

Report on the strategy that WP3 will follow to perform co-design activities with other partners in the project and external stakeholders.

D6.5 Co-design strategy for WP6

Report on the strategy that WP6 will follow to perform co-design activities with other partners in the project and external stakeholders.

D1.6 Co-design strategy for WP1

Report on the strategy that WP1 will follow to perform co-design activities with other partners in the project and external stakeholders.

D8.9 Plans and processes for the governance of the Project

Summary document describing plans and processes for the governance of the Project ready

D2.4 Strategy for 5M connectome data acquisition

Report on the strategy to follow during the multi-site acquisition of the 5M connectome dataset

D4.4 Co-design strategy for WP4

Report on the strategy that WP4 will follow to perform co-design activities with other partners in the project and external stakeholders.

D5.5 Co-design strategy for WP5

Report on the strategy that WP5 will follow to perform co-design activities with other partners in the project and external stakeholders.

D2.5 Co-design strategy for WP2

Develop a co-design activity in which members of the EAN will be polled about their competence and interest on new connectomics methods to study clinical conditions.